Your browser doesn't support javascript.
loading
[Research progress in systemic lupus erythematosus from 2021 to 2022]. / 2021­2022年度系统性红斑狼疮研究进展盘点.
Li, Yong-Zhen; Wu, Xiao-Chuan.
Afiliação
  • Li YZ; Department of Pediatrics, Second Xiangya Hospital, Central South University, Changsha 410000, China.
  • Wu XC; Department of Pediatrics, Second Xiangya Hospital, Central South University, Changsha 410000, China.
Zhongguo Dang Dai Er Ke Za Zhi ; 25(8): 785-790, 2023 Aug 15.
Article em Zh | MEDLINE | ID: mdl-37668024
ABSTRACT
Systemic lupus erythematosus (SLE) is an autoimmune disease that affects multiple organ systems, presenting a complex and diverse clinical manifestation. The heterogeneous treatment response and prognosis of SLE pose significant challenges to its diagnosis, classification, and homogeneous treatment. The emergence of new technologies and fields, such as synthetic biology, genomics, and proteomics, has contributed to a deeper exploration of the pathogenesis and biomarkers of SLE, facilitating precision diagnosis and treatment. This review summarizes the latest research data and achievements in SLE for the years 2021-2022, providing an overview and summary of relevant studies conducted in the past two years.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Lúpus Eritematoso Sistêmico Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: Zh Revista: Zhongguo Dang Dai Er Ke Za Zhi Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Lúpus Eritematoso Sistêmico Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: Zh Revista: Zhongguo Dang Dai Er Ke Za Zhi Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China